In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis
about
Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patientsIn vitro interactions between new antitubercular drug candidates SQ109 and TMC207.In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TBEffectiveness of tuberculosis chemotherapy correlates with resistance to Mycobacterium tuberculosis infection in animal modelsMoxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis: evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy.In vitro antimycobacterial activities of capuramycin analogues.Acquired rifamycin resistance: pharmacology and biology.New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis.Modeling in vivo pharmacokinetics and pharmacodynamics of moxifloxacin therapy for Mycobacterium tuberculosis infection by using a novel cartridge systemThe early bactericidal activities of rifampin and rifapentine in pulmonary tuberculosis.A rifapentine-containing inhaled triple antibiotic formulation for rapid treatment of tubercular infection.
P2860
Q28534495-B51871C1-2FB5-46E2-BBE5-0878B06DE101Q33962793-209CF27F-7701-4062-9ED1-A4FEBF77B1F5Q34591451-7B7B3AEC-807C-4C37-B2DE-CBE9A1AF3BB4Q35037392-781C5965-18A5-434E-B2BE-449FE837B8D0Q35636012-65664ED6-FDD6-45D3-A76B-E51F1F5C2E0CQ36424956-C51A2256-25BD-4F14-9183-64D3DF283647Q37124893-97F59FED-62C2-4959-8866-915CAB11A0D6Q37346929-6E822600-23F8-4732-8F54-84D3FA37CCFFQ39456569-71BD568D-C7FB-4F4B-8D85-970DD067FABFQ41003618-2256E8A4-D5D9-440C-B4AC-614B5CB3A714Q46417486-D627981D-33FE-4DD2-974E-A43F14B4A5A5Q46650295-70AA3BE8-6961-468B-925A-FC9CF8E1B8CD
P2860
In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
In vitro postantibiotic effect ...... nst Mycobacterium tuberculosis
@en
type
label
In vitro postantibiotic effect ...... nst Mycobacterium tuberculosis
@en
prefLabel
In vitro postantibiotic effect ...... nst Mycobacterium tuberculosis
@en
P2093
P2860
P1476
In vitro postantibiotic effect ...... nst Mycobacterium tuberculosis
@en
P2093
Augustine F B Cheng
Carrie Au-Yeang
Chi-Chiu Leung
Chiu-Yeung Chan
Wing-Wai Yew
P2860
P304
P356
10.1128/AAC.48.1.340-343.2004
P407
P577
2004-01-01T00:00:00Z